Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 80425-0094

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 80425-0094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2

A line graph depicting mean daytime heartburn scores over 28 study days for three groups: placebo, Rabeprazole Sodium 10 mg, and Rabeprazole Sodium 20 mg. The y-axis shows mean heartburn scores from 0 (none) to 4 (very severe), and the x-axis shows study days from -14 to 28. Heartburn scores decrease notably after day 0 for Rabeprazole groups compared to placebo.*

FDA Label Image

Figure 4

A line graph titled 'Mean Daytime Heartburn Scores RAB-USA-3' showing mean heartburn scores over study days from -14 to 28. Two groups are compared: Placebo (n=58) and Rabeprazole Sodium 20 mg (n=59). The vertical axis represents mean heartburn scores from 0 (None) to 4 (Very Severe). The graph shows a decrease in scores for the Rabeprazole group following day 0 compared to placebo.*

FDA Label Image

Figure 5

A line graph showing mean nighttime heartburn scores over a 42-day period, including 14 days before and 28 days after study day 0. It compares two groups: placebo (n=58) and Rabeprazole Sodium 20 mg (n=59). Scores range from 0 (None) to 4 (Very Severe), with the Rabeprazole group consistently showing lower scores than placebo after day 0.*

FDA Label Image

Rabeprazole Sodium Dr Qty 30 Ndc 80425 0094

Label for Rabeprazole Sodium DR 20 mg delayed-release tablets by Advanced Rx of Tennessee, LLC. The label includes product name, strength, quantity (#30), storage instructions at room temperature (20°-25°C or 68°-77°F), a lot number, expiration date (8/31/2022), barcodes, and a caution regarding federal law prohibiting unauthorized transfer of the drug.*

FDA Label Image

Rabeprazole Sodium Dr Qty 60 Ndc 80425 0094

Label for Rabeprazole Sodium DR 20 mg delayed-release tablets by Advanced Rx of Tennessee, LLC. The label includes the product name, strength, quantity (#60), comparison to ACIPHEX, NDC 80425-0094-02, lot number 60RAB20922, expiration 9/30/2022, storage instructions at 20°-25°C, and manufacturer Ascend Laborato. A barcode and a QR code are present.*

FDA Label Image

Structure

Chemical structure of Rabeprazole Sodium showing its molecular arrangement with sodium ion (Na), a sulfur atom bonded to oxygen, and a methoxyethyl side chain attached to a pyridine and benzimidazole ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.